ASX - By Stock
|
PAB |
Re:
Ann: Positive preclinical data for deoxymabs in vasculitis
|
|
Dale123
|
60 |
22K |
3 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
60
|
22K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Positive preclinical data for deoxymabs in vasculitis
|
|
Dale123
|
60 |
22K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
60
|
22K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
Dale123
|
89 |
34K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
89
|
34K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
Dale123
|
89 |
34K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
89
|
34K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Chair's Address and CEO Presentation to 2023 AGM
|
|
Dale123
|
74 |
27K |
0 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
74
|
27K
|
0
|
|
ASX - By Stock
|
IBX Biotech |
Re:
Consolidation in effect today
|
|
Dale123
|
153 |
59K |
1 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
153
|
59K
|
1
|
|
ASX - By Stock
|
ROG |
Re:
Ann: Killanoola DEM Production Approval
|
|
Dale123
|
374 |
91K |
4 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
374
|
91K
|
4
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
Dale123
|
74 |
36K |
3 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
74
|
36K
|
3
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
Dale123
|
74 |
36K |
11 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
74
|
36K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Retirement of Non-Executive Director
|
|
Dale123
|
11 |
5.1K |
0 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
11
|
5.1K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Retirement of Non-Executive Director
|
|
Dale123
|
11 |
5.1K |
2 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
11
|
5.1K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Application for quotation of securities - PAB
|
|
Dale123
|
24 |
5.4K |
1 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
24
|
5.4K
|
1
|
|
ASX - By Stock
|
ROG |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Dale123
|
386 |
93K |
11 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
386
|
93K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
Looking forward to the next 12 months with great excitement.
|
|
Dale123
|
98 |
42K |
0 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
98
|
42K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Looking forward to the next 12 months with great excitement.
|
|
Dale123
|
98 |
42K |
1 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
98
|
42K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Investor Webinar Participation
|
|
Dale123
|
15 |
5.3K |
1 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
15
|
5.3K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Abysmal shareholder communication
|
|
Dale123
|
78 |
28K |
2 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
78
|
28K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
PAB TOP Holders
|
|
Dale123
|
140 |
63K |
5 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
140
|
63K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
Dale123
|
348 |
130K |
2 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
348
|
130K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
Dale123
|
348 |
130K |
2 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
348
|
130K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT DX3 Crosses Blood Brain Barrier in Healthy Animals
|
|
Dale123
|
55 |
22K |
13 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
55
|
22K
|
13
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Dale123
|
12 |
4.5K |
2 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
12
|
4.5K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
PABO and PABOA strike price?
|
|
Dale123
|
58 |
29K |
1 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
58
|
29K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: New Research Grant For Deoxymabs in Metastatic Breast Cancer
|
|
Dale123
|
10 |
4.0K |
10 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
10
|
4.0K
|
10
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1/Radiation Combination Improves Brain Cancer Survival
|
|
Dale123
|
25 |
10K |
11 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
25
|
10K
|
11
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Dale123
|
77 |
24K |
1 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
77
|
24K
|
1
|
|
ASX - By Stock
|
BAS |
Re:
Ann: Reserves and Contingent Resources - 31 December 2021
|
|
Dale123
|
32 |
8.3K |
1 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
32
|
8.3K
|
1
|
|
ASX - By Stock
|
BAS |
Re:
Ann: Reserves and Contingent Resources - 31 December 2021
|
|
Dale123
|
32 |
8.3K |
1 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
32
|
8.3K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Feedback for IBX management
|
|
Dale123
|
5 |
2.5K |
3 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
5
|
2.5K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Successful completion of Institutional Entitlement Offer
|
|
Dale123
|
10 |
3.6K |
1 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
10
|
3.6K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $18.1 million
|
|
Dale123
|
78 |
25K |
12 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
78
|
25K
|
12
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
Dale123
|
5.5K |
1.9M |
11 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
5.5K
|
1.9M
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $18.1 million
|
|
Dale123
|
78 |
25K |
1 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
78
|
25K
|
1
|
|
ASX - By Stock
|
ADG |
Re:
Ann: Raise $900,000 to Progress Drilling & Finalise Scoping Study
|
|
Dale123
|
43 |
13K |
7 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
43
|
13K
|
7
|
|
ASX - By Stock
|
ADG |
Re:
Ann: Trading Halt
|
|
Dale123
|
44 |
13K |
12 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
44
|
13K
|
12
|
|
ASX - By Stock
|
ADG |
Re:
Ann: 2021 Quarterly Activities Report & Appendix 5B
|
|
Dale123
|
15 |
3.8K |
4 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
15
|
3.8K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 engineering update
|
|
Dale123
|
176 |
58K |
1 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
176
|
58K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 engineering update
|
|
Dale123
|
176 |
58K |
2 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
176
|
58K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Predictions On The Upcoming Quarterly
|
|
Dale123
|
104 |
43K |
10 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
104
|
43K
|
10
|
|
ASX - By Stock
|
PAB |
Re:
PAB - A new day is dawning ‘2022’
|
|
Dale123
|
124 |
40K |
12 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
124
|
40K
|
12
|
|
ASX - By Stock
|
IBX |
Re:
Predictions On The Upcoming Quarterly
|
|
Dale123
|
104 |
43K |
15 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
104
|
43K
|
15
|
|
ASX - By Stock
|
IBX |
Re:
Predictions On The Upcoming Quarterly
|
|
Dale123
|
104 |
43K |
1 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
104
|
43K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
PAB - A new day is dawning ‘2022’
|
|
Dale123
|
124 |
40K |
9 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
124
|
40K
|
9
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change of Director's Interest Notices x2
|
|
Dale123
|
204 |
65K |
3 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
204
|
65K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
PAB - A new day is dawning ‘2022’
|
|
Dale123
|
124 |
40K |
1 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
124
|
40K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change of Director's Interest Notices x2
|
|
Dale123
|
204 |
65K |
5 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
204
|
65K
|
5
|
|
ASX - By Stock
|
ADG |
Re:
Ann: Investor Presentation - Adelong Project
|
|
Dale123
|
103 |
30K |
10 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
103
|
30K
|
10
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change of Director's Interest Notices x2
|
|
Dale123
|
204 |
65K |
1 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
204
|
65K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
Dale123
|
5.5K |
1.9M |
14 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
5.5K
|
1.9M
|
14
|
|
ASX - By Stock
|
ADG |
Re:
cosmo
|
|
Dale123
|
7 |
3.0K |
1 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
7
|
3.0K
|
1
|
|